Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

1.

Pancreatic neuroendocrine neoplasms: The latest surgical and medical treatment strategies based on the current World Health Organization classification.

Ishida H, Lam AK.

Crit Rev Oncol Hematol. 2020 Jan;145:102835. doi: 10.1016/j.critrevonc.2019.102835. Epub 2019 Nov 27. Review.

PMID:
31864179
2.

MUC1 as a target for CAR-T therapy in head and neck squamous cell carinoma.

Mei Z, Zhang K, Lam AK, Huang J, Qiu F, Qiao B, Zhang Y.

Cancer Med. 2020 Jan;9(2):640-652. doi: 10.1002/cam4.2733. Epub 2019 Dec 4.

3.

Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells.

Zhou Y, Chung PY, Ma JY, Lam AK, Law S, Chan KW, Chan AS, Li X, Lam KH, Chui CH, Tang JC.

Biology (Basel). 2019 Oct 1;8(4). pii: E75. doi: 10.3390/biology8040075.

4.

Factors affecting the approaches and complications of surgery in childhood papillary thyroid carcinomas.

Fridman M, Krasko O, Branovan DI, Dabryian S, Pisarenko A, Lo CY, Lam AK.

Eur J Surg Oncol. 2019 Nov;45(11):2078-2085. doi: 10.1016/j.ejso.2019.07.032. Epub 2019 Aug 1.

PMID:
31395293
5.

Characterization of Mucosa-Associated Microbiota in Matched Cancer and Non-neoplastic Mucosa From Patients With Colorectal Cancer.

Leung PHM, Subramanya R, Mou Q, Lee KT, Islam F, Gopalan V, Lu CT, Lam AK.

Front Microbiol. 2019 Jun 12;10:1317. doi: 10.3389/fmicb.2019.01317. eCollection 2019.

6.

GAEC1 drives colon cancer progression.

Lee KT, Vider J, Tang JC, Gopalan V, Lam AK.

Mol Carcinog. 2019 Jul;58(7):1145-1154. doi: 10.1002/mc.22998. Epub 2019 Mar 1.

PMID:
30825264
7.

The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancer.

Mamoori A, Wahab R, Vider J, Gopalan V, Lam AK.

Gene. 2019 May 20;697:165-174. doi: 10.1016/j.gene.2019.02.046. Epub 2019 Feb 22.

PMID:
30802541
8.

FAM134B promotes esophageal squamous cell carcinoma in vitro and its correlations with clinicopathologic features.

Islam F, Gopalan V, Law S, Tang JC, Lam AK.

Hum Pathol. 2019 May;87:1-10. doi: 10.1016/j.humpath.2018.11.033. Epub 2019 Feb 20.

PMID:
30794892
9.

Roles of long-non-coding RNAs in cancer therapy through the PI3K/Akt signalling pathway.

Lee KT, Gopalan V, Lam AK.

Histol Histopathol. 2019 Jun;34(6):593-609. doi: 10.14670/HH-18-081. Epub 2019 Jan 8. Review.

PMID:
30620381
10.

BRAF mutation: Current and future clinical pathological applications in colorectal carcinoma.

Ng JY, Lu CT, Lam AK.

Histol Histopathol. 2019 May;34(5):469-477. doi: 10.14670/HH-18-079. Epub 2018 Dec 28. Review.

PMID:
30592501
11.

Hereditary breast cancer; Genetic penetrance and current status with BRCA.

Mahdavi M, Nassiri M, Kooshyar MM, Vakili-Azghandi M, Avan A, Sandry R, Pillai S, Lam AK, Gopalan V.

J Cell Physiol. 2019 May;234(5):5741-5750. doi: 10.1002/jcp.27464. Epub 2018 Dec 14. Review.

PMID:
30552672
12.

Bone Invasive Properties of Oral Squamous Cell Carcinoma and its Interactions with Alveolar Bone Cells: An In Vitro Study.

Qallandar OB, Ebrahimi F, Islam F, Wahab R, Qiao B, Reher P, Gopalan V, Lam AK.

Curr Cancer Drug Targets. 2019;19(8):631-640. doi: 10.2174/1568009618666181102144317.

PMID:
30387395
13.

Targeting DNA Binding for NF-ÎşB as an Anticancer Approach in Hepatocellular Carcinoma.

Chung PY, Lam PL, Zhou YY, Gasparello J, Finotti A, Chilin A, Marzaro G, Gambari R, Bian ZX, Kwok WM, Wong WY, Wang X, Lam AK, Chan AS, Li X, Ma JY, Chui CH, Lam KH, Tang JC.

Cells. 2018 Oct 22;7(10). pii: E177. doi: 10.3390/cells7100177.

14.

Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma.

Chan D, Zhou Y, Chui CH, Lam KH, Law S, Chan AS, Li X, Lam AK, Tang JCO.

Cells. 2018 Sep 20;7(10). pii: E143. doi: 10.3390/cells7100143.

15.

Reproducibility of global left atrial strain and strain rate between novice and expert using multi-vendor analysis software.

Rausch K, Shiino K, Putrino A, Lam AK, Scalia GM, Chan J.

Int J Cardiovasc Imaging. 2019 Mar;35(3):419-426. doi: 10.1007/s10554-018-1453-7. Epub 2018 Sep 18.

PMID:
30229344
16.

Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation.

Ng HY, Li J, Tao L, Lam AK, Chan KW, Ko JMY, Yu VZ, Wong M, Li B, Lung ML.

Transl Oncol. 2018 Dec;11(6):1323-1333. doi: 10.1016/j.tranon.2018.08.005. Epub 2018 Aug 31.

17.

Tumour suppressor properties of miR-15a and its regulatory effects on BCL2 and SOX2 proteins in colorectal carcinomas.

Gopalan V, Ebrahimi F, Islam F, Vider J, Qallandar OB, Pillai S, Lu CT, Lam AK.

Exp Cell Res. 2018 Sep 15;370(2):245-253. doi: 10.1016/j.yexcr.2018.06.025. Epub 2018 Jun 26.

PMID:
29958837
18.

Sox2 promotes tumor aggressiveness and epithelial‑mesenchymal transition in tongue squamous cell carcinoma.

Liu X, Qiao B, Zhao T, Hu F, Lam AK, Tao Q.

Int J Mol Med. 2018 Sep;42(3):1418-1426. doi: 10.3892/ijmm.2018.3742. Epub 2018 Jun 26.

19.

Interactions of Vascular Endothelial Growth Factor and p53 with miR-195 in Thyroid Carcinoma: Possible Therapeutic Targets in Aggressive Thyroid Cancers.

Maroof H, Irani S, Arianna A, Vider J, Gopalan V, Lam AK.

Curr Cancer Drug Targets. 2019;19(7):561-570. doi: 10.2174/1568009618666180628154727.

PMID:
29956628
20.

The role of heme iron molecules derived from red and processed meat in the pathogenesis of colorectal carcinoma.

Gamage SMK, Dissabandara L, Lam AK, Gopalan V.

Crit Rev Oncol Hematol. 2018 Jun;126:121-128. doi: 10.1016/j.critrevonc.2018.03.025. Epub 2018 Apr 7. Review.

PMID:
29759553

Supplemental Content

Loading ...
Support Center